Milestone Scientific Inc. balance sheet
At the end of fiscal 2025, Milestone Scientific Inc. had total assets of $7.8m, total liabilities of $5.0m and shareholders' equity of $2.8m. It held $1.1m in cash against $800,000 of debt.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1 | 0 | 0 | 1 | 10 | 4 | 4 | 3 | 2 | 2 | 14 | 15 | 9 | 3 | 3 | 1 | — |
| Receivables | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | — | — |
| Inventory | 1 | 1 | 1 | 1 | 2 | 4 | 5 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 3 |
| Total current assets | 3 | 3 | 2 | 5 | 16 | 12 | 13 | 12 | 6 | 6 | 19 | 19 | 13 | 11 | 9 | 7 | 8 |
| Total assets | 7 | 7 | 6 | 8 | 17 | 13 | 14 | 16 | 6 | 7 | 20 | 20 | 14 | 11 | 10 | 8 | 8 |
| Accounts payable | 3 | 4 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | 1 | 2 | 0 | — | — | — | — | — | — | — | — |
| Total current liabilities | 3 | 5 | 3 | 3 | 2 | 4 | 6 | 7 | 5 | 5 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Long-term debt | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | 0 | 1 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total liabilities | — | — | 4 | 3 | 2 | — | 6 | 8 | 5 | 5 | 3 | 4 | 4 | 3 | 4 | 5 | 5 |
| Shareholders' equity | 2 | 2 | 2 | 6 | 15 | 10 | 9 | 7 | 2 | 2 | 16 | 16 | 10 | 8 | 6 | 3 | 3 |
| Shares outstanding | 15m | 16m | 17m | 18m | 21m | 22m | 30m | 33m | 34m | 49m | 64m | 68m | 69m | 76m | 78m | 80m | 89m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1 | 0 | — | — | — | — | — | — |
| Inventory | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
| Total current assets | 11 | 9 | 9 | 8 | 8 | 7 | 7 | 8 |
| Total assets | 11 | 10 | 9 | 8 | 8 | 8 | 8 | 8 |
| Total current liabilities | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 4 |
| Long-term debt | — | 0 | — | 1 | 1 | 1 | 1 | 0 |
| Total debt | — | 0 | — | 1 | 1 | 1 | 1 | 0 |
| Total liabilities | 4 | 4 | 5 | 5 | 6 | 5 | 6 | 5 |
| Shareholders' equity | 7 | 6 | 4 | 3 | 3 | 3 | 2 | 3 |
| Shares outstanding | 78m | 78m | 78m | 79m | 79m | 80m | 80m | 89m |
Compare with peers
- Neuroone Medical Technologies Corp balance sheet
- Nuwellis, Inc. balance sheet
- Work Medical Technology Group LTD balance sheet
- Anbio Biotechnology balance sheet
- Inspiremd, Inc. balance sheet
Head to head: MLSS vs NMTCMLSS vs NUWEMLSS vs WOKMLSS vs NNNN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies